Defibrillator versus β-blockers for unexplained death in Thailand (DEBUT): A randomized clinical trial

Circulation

Volumn 107, Issue 17, 2003, Pages 2221-2226

  Nademanee, Koonlawee ^a   Veerakul, Gumpanart ^b   Mower, Morton ^c   Likittanasombat, Khanchit ^d   Krittayapong, Rungroj ^d   Bhuripanyo, Kiertijai ^d   Sitthisook, Surapun ^e   Chaothawee, Lertlak ^b   Lai, Mei Ying ^f   Azen, Stanley P ^f  

^a Pacific Rim Electrophysiology Research Institute   (United States)

^b Royal Thai Air Force   (Thailand)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d MAHIDOL UNIVERSITY   (Thailand)

^e CHULALONGKORN UNIVERSITY   (Thailand)

^f UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Death; Defibrillators; Fibrillation; Implantable; Propranolol; Sudden

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; PROPRANOLOL;

ADULT; AGED; ARTICLE; ASIA; BETA ADRENERGIC RECEPTOR BLOCKING; CAUSE OF DEATH; CLINICAL RESEARCH; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEFIBRILLATOR; DRUG MONITORING; DRUG SAFETY; FEMALE; FOLLOW UP; HEART ARREST; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HOSPITAL DISCHARGE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; POPULATION RISK; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; SUDDEN DEATH; SUDDEN UNEXPLAINED DEATH SYNDROME; SURVIVAL; THAILAND; TREATMENT OUTCOME;

ADRENERGIC BETA-ANTAGONISTS; ADULT; ARRHYTHMIA; DEATH, SUDDEN; DEFIBRILLATORS, IMPLANTABLE; ELECTROCARDIOGRAPHY; FEMALE; HUMANS; MALE; MIDDLE AGED; PILOT PROJECTS; PROPRANOLOL; SURVIVAL RATE; SYNDROME; THAILAND; VENTRICULAR FIBRILLATION;

EID: 0037696634     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.0000066319.56234.C8     Document Type: Article

References (19)

1. US Centers for Disease Control. Update: sudden unexplained death syndrome among Southeast Asian refugees: United States. MMWR Morb Mortal Wkly Rep. 1988;87:568-570.
2. Goh KT, Chao TC, Chew CH. Sudden nocturnal deaths among Thai construction workers in Singapore. Lancet. 1990;335:1154.
3. Nademanee K, Veerakul G, Nimmannit S, et al. Arrhythmogenic marker for the sudden unexplained death syndrome in Thai men. Circulation. 1997;96:2595-2600.
4. Aponte GE. The enigma of bangungut. Ann Intern Med. 1960;52: 1258-1263.
5. Sugai M. A pathological study on sudden and unexpected death, especially on the cardiac death autopsied by medical examiners in Tokyo. Acta Pathol Jpn 1959;9(suppl):723-752.
6. Gotoh K. A histopathological study on the conduction system of the so-called "pokkuri disease" (sudden unexpected cardiac death of unknown origin in Japan). Jpn Circ J. 1976;40:752-768.
7. Brugada P, Brugada J. Right bundle branch block, persistent ST segment elevation and sudden cardiac death: a distinct clinical and electrocardiographic syndrome: a multicenter report. J Am Coll Cardiol. 1992;20: 1391-1396.
8. Antzelevitch C, Brugada P, Brugada J, et al. The Brugada Syndrome. Armonk, NY: Futura Publishing Company; 1999:1-99.
9. O'Brien PC, Fleming TR. A multiple testing procedure for clinical trials. Biometrics. 1979;35:545-556.
10. Bjerregaard P, Gussak I, Kotar SL, et al. Recurrent syncope in a patient with prominent-wave. Am Heart J. 1994;127:1426-1430.
11. Kasanuki H, Ohnishi S, Ohtuka M, et al. Idiopathic ventricular fibrillation induced with vagal activity in patients without obvious heart disease. Circulation. 1997;95:2277-2285.
12. Miyazaki T, Mitamura H, Miyoshi S, et al. Autonomic and antiarrhythmic drug modulation of ST segment elevation in patients with Brugada Syndrome. J Am Coll Cardiol. 1996;27:1061-1070.
13. Anderson JL, Hallstrom AP, Epstein AE, et al. Design and results of the antiarrhythmics vs implantable defibrillators (AVID) registry: The AVID Investigators. Circulation. 1999;99:1692-1699.
14. Moss AJ. Background outcome and clinical implications of the Multicenter Automatic Defibrillator Implantation Trial (MADIT). Am J Cardiol. 1997;80:28F-32F.
15. Buxton AE, Fisher JD, Josephson ME, et al. Prevention of sudden death in patients with coronary artery disease: the Multicenter Unsustained Tachycardia Trial (MUSTT). Prog Cardiovasc Dis. 1993;36:215-226.
16. Chen Q, Kirsch GE, Zhang D, et al. Genetic basis and molecular mechanism for idiopathic ventricular fibrillation. Nature. 1998;392: 293-296.
17. Vatta M, Dumaine R, Antzelevitch C, et al. Novel mutations in domain I of SCN5A cause Brugada Syndrome. Mol Genet Metab. 2002;75: 317-324.
18. + channel mutation causing both Long-QT and Brugada syndromes. Circ Res. 1999;85:1206-1213.
19. Priori SG, Napolitano C, Schwartz PJ, et al. The elusive link between LQT3 and Brugada syndrome: the role of flecainide challenge. Circulation. 2000;102:945-947.